Eucrates Biomedical Acquisition Corp. - FORM S-1/A - EX-4.2 - EXHIBIT 4.2 - October 15, 2020

Attached files

file filename
EX-4.3 - EXHIBIT 4.3 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex4-3.htm
EX-99.2 - EXHIBIT 99.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex99-2.htm
EX-99.1 - EXHIBIT 99.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex99-1.htm
EX-23.1 - EXHIBIT 23.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex23-1.htm
EX-14 - EXHIBIT 14 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex14.htm
EX-10.6 - EXHIBIT 10.6 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-6.htm
EX-10.5 - EXHIBIT 10.5 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-5.htm
EX-10.4 - EXHIBIT 10.4 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-4.htm
EX-10.3 - EXHIBIT 10.3 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-3.htm
EX-10.2 - EXHIBIT 10.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-2.htm
EX-10.1 - EXHIBIT 10.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex10-1.htm
EX-5.2 - EXHIBIT 5.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex5-2.htm
EX-5.1 - EX-5.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex5-1.htm
EX-4.4 - EXHIBIT 4.4 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex4-4.htm
EX-4.1 - EXHIBIT 4.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex4-1.htm
EX-3.2 - EXHIBIT 3.2 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex3-2.htm
EX-3.1 - EXHIBIT 3.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex3-1.htm
EX-1.1 - EXHIBIT 1.1 - Eucrates Biomedical Acquisition Corp.tm2029948d6_ex1-1.htm
S-1/A - S-1/A - Eucrates Biomedical Acquisition Corp.tm2029948-5_s1a.htm

Exhibit 4.2

 

Share certificate

Number of certificate  Number of shares
    
    

 

EUCRATES BIOMEDICAL ACQUISITION CORP.

 

Company number 2042314

 

(COMPANY)

 

INCORPORATED UNDER THE BVI BUSINESS COMPANY ACT, 2004, AS AMENDED

 

This is to certify that __________________ of ________________________________________________ is the registered holder of ________________________ ordinary shares of no par value each being fully paid in the above-named company, subject to the memorandum and articles of association of the company.

 

Given under the Common Seal of the Company this _________________________________

 

   
Director  

 

 

Eucrates Biomedical Acquisition Corp. Reports